Cogent Biosciences (COGT) Competitors $7.86 +0.10 (+1.29%) (As of 01:00 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends COGT vs. PTCT, VRNA, RYTM, MLTX, EWTX, JANX, XENE, MRUS, ACAD, and TWSTShould you be buying Cogent Biosciences stock or one of its competitors? The main competitors of Cogent Biosciences include PTC Therapeutics (PTCT), Verona Pharma (VRNA), Rhythm Pharmaceuticals (RYTM), MoonLake Immunotherapeutics (MLTX), Edgewise Therapeutics (EWTX), Janux Therapeutics (JANX), Xenon Pharmaceuticals (XENE), Merus (MRUS), ACADIA Pharmaceuticals (ACAD), and Twist Bioscience (TWST). These companies are all part of the "pharmaceutical products" industry. Cogent Biosciences vs. PTC Therapeutics Verona Pharma Rhythm Pharmaceuticals MoonLake Immunotherapeutics Edgewise Therapeutics Janux Therapeutics Xenon Pharmaceuticals Merus ACADIA Pharmaceuticals Twist Bioscience Cogent Biosciences (NASDAQ:COGT) and PTC Therapeutics (NASDAQ:PTCT) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, community ranking, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Does the media refer more to COGT or PTCT? In the previous week, PTC Therapeutics had 2 more articles in the media than Cogent Biosciences. MarketBeat recorded 6 mentions for PTC Therapeutics and 4 mentions for Cogent Biosciences. Cogent Biosciences' average media sentiment score of 0.99 beat PTC Therapeutics' score of 0.26 indicating that Cogent Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cogent Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PTC Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation and earnings, COGT or PTCT? Cogent Biosciences has higher earnings, but lower revenue than PTC Therapeutics. PTC Therapeutics is trading at a lower price-to-earnings ratio than Cogent Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCogent BiosciencesN/AN/A-$192.41M-$2.48-3.15PTC Therapeutics$900.66M3.91-$626.60M-$5.94-7.70 Does the MarketBeat Community favor COGT or PTCT? PTC Therapeutics received 274 more outperform votes than Cogent Biosciences when rated by MarketBeat users. However, 70.69% of users gave Cogent Biosciences an outperform vote while only 61.85% of users gave PTC Therapeutics an outperform vote. CompanyUnderperformOutperformCogent BiosciencesOutperform Votes28770.69% Underperform Votes11929.31% PTC TherapeuticsOutperform Votes56161.85% Underperform Votes34638.15% Is COGT or PTCT more profitable? Cogent Biosciences has a net margin of 0.00% compared to PTC Therapeutics' net margin of -50.32%. PTC Therapeutics' return on equity of 0.00% beat Cogent Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Cogent BiosciencesN/A -112.55% -60.44% PTC Therapeutics -50.32%N/A -16.44% Which has more volatility & risk, COGT or PTCT? Cogent Biosciences has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500. Comparatively, PTC Therapeutics has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Do analysts prefer COGT or PTCT? Cogent Biosciences currently has a consensus target price of $14.83, suggesting a potential upside of 89.93%. PTC Therapeutics has a consensus target price of $54.08, suggesting a potential upside of 18.30%. Given Cogent Biosciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Cogent Biosciences is more favorable than PTC Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cogent Biosciences 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57PTC Therapeutics 3 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.47 SummaryCogent Biosciences beats PTC Therapeutics on 9 of the 16 factors compared between the two stocks. Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COGT vs. The Competition Export to ExcelMetricCogent BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$862.71M$6.70B$5.21B$9.23BDividend YieldN/A3.00%5.12%4.30%P/E Ratio-3.1510.6187.6917.23Price / SalesN/A193.791,166.33121.51Price / CashN/A57.1643.2337.84Price / Book3.405.144.814.92Net Income-$192.41M$151.58M$120.46M$225.43M7 Day Performance-4.64%-1.59%-0.85%0.61%1 Month Performance-14.46%-3.93%15.42%2.23%1 Year Performance36.06%8.90%29.98%16.55% Cogent Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGTCogent Biosciences1.4487 of 5 stars$7.86+1.3%$14.83+88.7%+35.2%$868.23MN/A-3.1780PTCTPTC Therapeutics3.6618 of 5 stars$47.77+3.0%$54.08+13.2%+65.0%$3.68B$937.82M-7.811,410Positive NewsVRNAVerona Pharma0.9532 of 5 stars$43.32+4.6%$43.83+1.2%+157.9%$3.52B$460,000.00-21.5730Positive NewsRYTMRhythm Pharmaceuticals4.1093 of 5 stars$56.23+1.8%$63.70+13.3%+20.9%$3.46B$77.43M-12.76140Analyst ForecastNews CoverageMLTXMoonLake Immunotherapeutics1.6482 of 5 stars$52.07+1.4%$79.88+53.4%-13.3%$3.33BN/A-39.802EWTXEdgewise Therapeutics2.5513 of 5 stars$34.97+26.6%$42.33+21.1%+221.3%$3.31BN/A-22.8560Gap UpHigh Trading VolumeJANXJanux Therapeutics3.7031 of 5 stars$62.25+1.9%$89.90+44.4%+436.9%$3.27B$13.05M-52.2330Positive NewsXENEXenon Pharmaceuticals2.8531 of 5 stars$41.15+2.7%$56.90+38.3%-14.5%$3.14B$9.43M-14.20251MRUSMerus2.2609 of 5 stars$42.84+0.0%$85.64+99.9%+56.8%$2.93B$43.95M-10.8437ACADACADIA Pharmaceuticals3.8781 of 5 stars$17.50+1.4%$25.60+46.3%-45.3%$2.91B$726.44M22.13510TWSTTwist Bioscience2.6059 of 5 stars$48.94+3.0%$51.90+6.0%+30.9%$2.91B$312.97M-13.19990 Related Companies and Tools Related Companies PTC Therapeutics Alternatives Verona Pharma Alternatives Rhythm Pharmaceuticals Alternatives MoonLake Immunotherapeutics Alternatives Edgewise Therapeutics Alternatives Janux Therapeutics Alternatives Xenon Pharmaceuticals Alternatives Merus Alternatives ACADIA Pharmaceuticals Alternatives Twist Bioscience Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:COGT) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COGT Stock Alerts